Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 45577 questions Show Answers
To ask the Scottish Government what discussions it has had with the Police Investigations and Review Commissioner regarding any implications of any increased use of body-worn cameras for its case preparation workload, and whether any operational support is being considered.
To ask the Scottish Government what guidance or negotiations it has undertaken with COSLA to reduce teacher class contact time.
To ask the Scottish Government what COVID-19 vaccines are available for those who are immunocompromised and have a respiratory illness, in light of reports that VidPrevtyn, manufactured by Sanofi Paseur, is no longer available.
To ask the Scottish Government what its position is on whether local authorities are delivering additional support needs support to a consistent national standard.
To ask the Scottish Government whether it has estimated any impact on the processing times for case marking and prosecution decisions as a result of any need to review body-worn camera footage.
To ask the Scottish Government on what dates the National Infertility Group has met during the current parliamentary session.
To ask the Scottish Government what measures, other than BMI, are available to clinicians when making decisions about the health of a woman seeking access to NHS-funded IVF treatment.
To ask the Scottish Government what its proposed timetable is for legislation to reform additional support needs provision.
To ask the Scottish Government whether any costing or modelling has been done to deliver its commitment to reduce teacher class contact time.
To ask the Scottish Government, further to the announcement within the Programme for Government 2025-26 of £4.5 million for new specialist support for long COVID, myalgic encephalomyelitis (ME), chronic fatigue and other similar conditions, what it identifies as "similar conditions".